Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Hungnes

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Blood|November 8, 2011
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatmentOlav Erich Yri, Dag Torfoss, Olav Hungnes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayLamprini Veneti, Beatriz Valcarcel Salamanca, Elina Seppälä, et al.
Viruses|March 27, 2025
A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in NorwayAlaka Lamsal, Katrine Mørk Paulsen, Maria Juul Diekmann, et al.
European Journal of Epidemiology|January 18, 2020
Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort studyNina Gunnes, Håkon Kristian Gjessing, Inger Johanne Bakken, et al.
Plos One|October 11, 2021
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021Lamprini Veneti, Elina Seppälä, Margrethe Larsdatter Storm, et al.
BMC Infectious Diseases|August 20, 2024
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adultsGro Tunheim, Even Fossum, Anna Hayman Robertson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 28, 2022
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022Lamprini Veneti, Håkon Bøås, Anja Bråthen Kristoffersen, et al.
Transboundary and Emerging Diseases|February 23, 2026
Highly Pathogenic Avian Influenza A (H5N1) Caused Mass Death Among Black-Legged Kittiwakes (<i>Rissa tridactyla</i>) in Norway, 2023Grim Rømo, Caroline Piercey Åkesson, Tone Kristin Reiertsen, et al.
The Lancet. Infectious Diseases|December 22, 2011
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectivesAeron C Hurt, Tawee Chotpitayasunondh, Nancy J Cox, et al.
Frontiers in Pediatrics|September 26, 2022
The burden of hospital-attended influenza in Norwegian childrenHåkon Bøås, Terese Bekkevold, Lise Beier Havdal, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Blood|November 8, 2011
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatmentOlav Erich Yri, Dag Torfoss, Olav Hungnes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayLamprini Veneti, Beatriz Valcarcel Salamanca, Elina Seppälä, et al.
Viruses|March 27, 2025
A Retrospective Sero-Surveillance Study for Antibodies Against Tick-Borne Encephalitis Virus in NorwayAlaka Lamsal, Katrine Mørk Paulsen, Maria Juul Diekmann, et al.
European Journal of Epidemiology|January 18, 2020
Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort studyNina Gunnes, Håkon Kristian Gjessing, Inger Johanne Bakken, et al.
Plos One|October 11, 2021
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021Lamprini Veneti, Elina Seppälä, Margrethe Larsdatter Storm, et al.
BMC Infectious Diseases|August 20, 2024
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adultsGro Tunheim, Even Fossum, Anna Hayman Robertson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 28, 2022
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022Lamprini Veneti, Håkon Bøås, Anja Bråthen Kristoffersen, et al.
Transboundary and Emerging Diseases|February 23, 2026
Highly Pathogenic Avian Influenza A (H5N1) Caused Mass Death Among Black-Legged Kittiwakes (<i>Rissa tridactyla</i>) in Norway, 2023Grim Rømo, Caroline Piercey Åkesson, Tone Kristin Reiertsen, et al.
The Lancet. Infectious Diseases|December 22, 2011
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectivesAeron C Hurt, Tawee Chotpitayasunondh, Nancy J Cox, et al.
Frontiers in Pediatrics|September 26, 2022
The burden of hospital-attended influenza in Norwegian childrenHåkon Bøås, Terese Bekkevold, Lise Beier Havdal, et al.
Pageof 8